粪便微生物群移植：展望
Fecal microbiota transplantation: in perspective.
作者信息
Gupta Shaan, Allen-Vercoe Emma, Petrof Elaine O
机构信息
Department of Medicine, Gastrointestinal Diseases Research Unit, Queen's University, Kingston, ON, Canada.
Department of Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada.
出版信息
Therap Adv Gastroenterol. 2016 Mar;9(2):229-39. doi: 10.1177/1756283X15607414.
Abstract
There has been increasing interest in understanding the role of the human gut microbiome to elucidate the therapeutic potential of its manipulation. Fecal microbiota transplantation (FMT) is the administration of a solution of fecal matter from a donor into the intestinal tract of a recipient in order to directly change the recipient's gut microbial composition and confer a health benefit. FMT has been used to successfully treat recurrent Clostridium difficile infection. There are preliminary indications to suggest that it may also carry therapeutic potential for other conditions such as inflammatory bowel disease, obesity, metabolic syndrome, and functional gastrointestinal disorders.
摘要
人们对于了解人类肠道微生物群的作用以阐明其调控的治疗潜力的兴趣与日俱增。粪便微生物群移植（FMT）是将来自供体的粪便物质溶液输注到受体的肠道中，以便直接改变受体的肠道微生物组成并带来健康益处。FMT已被用于成功治疗复发性艰难梭菌感染。有初步迹象表明，它可能对其他病症如炎症性肠病、肥胖症、代谢综合征和功能性胃肠疾病也具有治疗潜力。
相似文献
1
Fecal microbiota transplantation: in perspective.粪便微生物群移植：展望
Therap Adv Gastroenterol. 2016 Mar;9(2):229-39. doi: 10.1177/1756283X15607414.
2
Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.复发性艰难梭菌感染和/或溃疡性结肠炎患者单次供体粪便微生物群移植的纵向微生物组分析
PLoS One. 2018 Jan 31;13(1):e0190997. doi: 10.1371/journal.pone.0190997. eCollection 2018.
3
Fecal Microbiota Transplantation as New Therapeutic Avenue for Human Diseases.粪便微生物群移植作为人类疾病的新治疗途径。
J Clin Med. 2022 Jul 15;11(14):4119. doi: 10.3390/jcm11144119.
4
Recurrent Clostridium difficile infection and the microbiome.艰难梭菌反复感染与微生物群
J Gastroenterol. 2016 Jan;51(1):1-10. doi: 10.1007/s00535-015-1099-3. Epub 2015 Jul 8.
5
Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases.粪便微生物群疗法在胃肠道和胃肠道外疾病治疗中的新兴作用。
J Physiol Pharmacol. 2015 Aug;66(4):483-91.
6
Fecal microbiota transplantation for gastrointestinal diseases.用于胃肠道疾病的粪便微生物群移植
Keio J Med. 2014;63(4):69-74. doi: 10.2302/kjm.2014-0006-RE. Epub 2014 Dec 15.
7
Contemporary Applications of Fecal Microbiota Transplantation to Treat Intestinal Diseases in Humans.粪便微生物群移植在人类肠道疾病治疗中的当代应用。
Arch Med Res. 2017 Nov;48(8):766-773. doi: 10.1016/j.arcmed.2017.11.006. Epub 2017 Nov 26.
8
Fecal microbiota transplantation: Review and update.粪便微生物群移植：综述与更新。
J Formos Med Assoc. 2019 Mar;118 Suppl 1:S23-S31. doi: 10.1016/j.jfma.2018.08.011. Epub 2018 Sep 1.
9
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update.粪便微生物群移植治疗溃疡性结肠炎及艰难梭菌感染以外的其他胃肠道疾病：最新进展
Drugs Today (Barc). 2018 Feb;54(2):123-136. doi: 10.1358/dot.2018.54.2.2760765.
10
[Current research progress and thinking of fecal microbiota transplantation for the treatment of gastrointestinal disorders].[粪便微生物群移植治疗胃肠道疾病的当前研究进展与思考]
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Oct 25;20(10):1104-1108.
引用本文的文献
1
Fecal microbiota transplantation as a therapeutic modality for recurrent infection: reviewing efficacy, safety, mechanisms of action, and outcomes.粪便微生物群移植作为复发性感染的一种治疗方式：疗效、安全性、作用机制及结果综述
Ann Med Surg (Lond). 2025 Jul 25;87(9):5829-5850. doi: 10.1097/MS9.0000000000003649. eCollection 2025 Sep.
2
Advancements in Immunomodulatory Therapies for IBD and Their Interplay With the Gut-Brain Axis: An Updated Review of Current Literature and Beyond.炎症性肠病免疫调节疗法的进展及其与肠-脑轴的相互作用：当前文献及其他相关研究的最新综述
Health Sci Rep. 2025 Aug 10;8(8):e71157. doi: 10.1002/hsr2.71157. eCollection 2025 Aug.
3
Microbiota-Host Interactions: Exploring Their Dynamics and Contributions to Human Diseases.微生物群与宿主的相互作用：探索它们的动态变化及其对人类疾病的影响。
Microbiologyopen. 2025 Aug;14(4):e70043. doi: 10.1002/mbo3.70043.
4
Cecal microbiota transplantation enhances calcium retention through modulation of gut microbiota and intestinal calcium transporter gene expression in chicks.盲肠微生物群移植通过调节雏鸡肠道微生物群和肠道钙转运蛋白基因表达来增强钙潴留。
Poult Sci. 2025 Jun 14;104(9):105437. doi: 10.1016/j.psj.2025.105437.
5
Pharmaco-psychiatry and gut microbiome: a systematic review of effects of psychotropic drugs for bipolar disorder.药物精神病学与肠道微生物群：双相情感障碍精神药物疗效的系统评价
Microbiology (Reading). 2025 Jun;171(6). doi: 10.1099/mic.0.001568.
6
The gut-heart axis: unveiling the roles of gut microbiota in cardiovascular diseases.肠-心轴：揭示肠道微生物群在心血管疾病中的作用
Front Cardiovasc Med. 2025 May 26;12:1572948. doi: 10.3389/fcvm.2025.1572948. eCollection 2025.
7
Gut Microbiota and Metabolic Dysregulation in Elderly Diabetic Patients: Is There a Gender-Specific Effect.老年糖尿病患者的肠道微生物群与代谢失调：是否存在性别特异性效应？
J Clin Med. 2025 Apr 30;14(9):3103. doi: 10.3390/jcm14093103.
8
Evolutionary medicine and bioastronautics: an innovative approach in addressing adverse mental health effects to astronauts during long term space missions.进化医学与生物航天学：应对长期太空任务中宇航员心理健康不良影响的创新方法。
Front Physiol. 2025 Apr 24;16:1558625. doi: 10.3389/fphys.2025.1558625. eCollection 2025.
9
A Novel Frontier in Gut-Brain Axis Research: The Transplantation of Fecal Microbiota in Neurodegenerative Disorders.肠道-脑轴研究的一个新前沿：粪便微生物群在神经退行性疾病中的移植。
Biomedicines. 2025 Apr 9;13(4):915. doi: 10.3390/biomedicines13040915.
10
The effects of repeated fecal transplantation and activated charcoal treatment on gut dysbiosis induced by concurrent ceftriaxone administration in mice.重复粪便移植和活性炭处理对小鼠同时给予头孢曲松所致肠道菌群失调的影响。
Sci Rep. 2025 Apr 22;15(1):13908. doi: 10.1038/s41598-025-96701-4.
本文引用的文献
1
Ecobiotherapy Rich in Firmicutes Decreases Susceptibility to Colitis in a Humanized Gnotobiotic Mouse Model.富含厚壁菌门细菌的生态疗法可降低人源化悉生小鼠模型对结肠炎的易感性。
Inflamm Bowel Dis. 2015 Aug;21(8):1883-93. doi: 10.1097/MIB.0000000000000422.
2
Potential Etiologic Factors of Microbiome Disruption in Autism.自闭症中微生物群破坏的潜在病因
Clin Ther. 2015 May 1;37(5):976-83. doi: 10.1016/j.clinthera.2015.04.001.
3
Weight gain after fecal microbiota transplantation.粪便微生物群移植后体重增加。
Open Forum Infect Dis. 2015 Feb 4;2(1):ofv004. doi: 10.1093/ofid/ofv004. eCollection 2015 Jan.
4
The metabolic syndrome.代谢综合征
S D Med. 2015;Spec No:24-8.
5
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook.2015年粪便微生物群移植最新进展：适应证、方法、机制及展望
Gastroenterology. 2015 Jul;149(1):223-37. doi: 10.1053/j.gastro.2015.05.008. Epub 2015 May 15.
6
Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review.粪菌移植作为胃肠病学的新型疗法：一项系统综述。
World J Gastroenterol. 2015 May 7;21(17):5359-71. doi: 10.3748/wjg.v21.i17.5359.
7
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.粪便微生物群移植在随机对照试验中诱导活动期溃疡性结肠炎患者缓解。
Gastroenterology. 2015 Jul;149(1):102-109.e6. doi: 10.1053/j.gastro.2015.04.001. Epub 2015 Apr 7.
8
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.粪便移植治疗溃疡性结肠炎的随机对照试验结果。
Gastroenterology. 2015 Jul;149(1):110-118.e4. doi: 10.1053/j.gastro.2015.03.045. Epub 2015 Mar 30.
9
Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease.粪菌移植对活动期克罗恩病临床结局及粪便微生物群的影响
Inflamm Bowel Dis. 2015 Mar;21(3):556-63. doi: 10.1097/MIB.0000000000000307.
10
Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)?粪便微生物群移植（FMT）对功能性胃肠疾病（FGID）患者是否为一种有效的治疗方法？
Neurogastroenterol Motil. 2015 Jan;27(1):19-29. doi: 10.1111/nmo.12479. Epub 2014 Nov 25.
Zotero 插件